Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC2A10 |
| Upstream (Parents) |
|---|
| (<<) MT1M → SLC2A10 |
| (<<) SLC16A2 → SLC2A10 |
| (<<) PECI → SLC2A10 |
| (<<) ANKRD55 → SLC2A10 |
| Downstream (Children) |
|---|
| SLC2A10 → PYGL (>>) |
| SLC2A10 → GALC (>>) |
| SLC2A10 → NUDCD3 (>>) |
| SLC2A10 → GPR37L1 (>>) |
| SLC2A10 → STXBP1 (>>) |
| SLC2A10 → NGFRAP1 (>>) |
| SLC2A10 → NAP1L2 (>>) |
| SLC2A10 → INTS1 (>>) |
| SLC2A10 → BDH2 (>>) |
| SLC2A10 → FKBP11 (>>) |
